American International Group, Inc. Maxcyte, Inc. Transaction History

American International Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$3.94 - $5.38 $1,453 - $1,985	-369 Reduced 0.85%	43,071 $180,000
Q4 2023 Feb 13, 2024	SELL	$2.6 - $5.24 $457 - $922	-176 Reduced 0.4%	43,440 $204,000
Q3 2023 Nov 13, 2023	BUY	$3.02 - $5.1 $4,684 - $7,910	1,551 Added 3.69%	43,616 $136,000
Q2 2023 Aug 04, 2023	SELL	$3.69 - $5.35 $1,730 - $2,509	-469 Reduced 1.1%	42,065 $193,000
Q1 2023 May 12, 2023	BUY	$4.03 - $5.89 $5,549 - $8,110	1,377 Added 3.35%	42,534 $210,000
Q4 2022 Feb 10, 2023	SELL	$4.92 - $7.4 $742 - $1,117	-151 Reduced 0.37%	41,157 $224,000
Q3 2022 Nov 14, 2022	BUY	$4.52 - $6.51 $2,635 - $3,795	583 Added 1.43%	41,308 $269,000
Q2 2022 Aug 12, 2022	SELL	$3.59 - $6.81 $31,904 - $60,520	-8,887 Reduced 17.91%	40,725 $193,000
Q1 2022 May 13, 2022	SELL	$5.26 - $10.84 $7,295 - $15,035	-1,387 Reduced 2.72%	49,612 $347,000
Q4 2021 Feb 11, 2022	BUY	$8.87 - $12.94 $376,292 - $548,953	42,423 Added 494.67%	50,999 $520,000
Q3 2021 Nov 12, 2021	BUY	$12.21 - $17.2 $104,712 - $147,507	8,576 New	8,576 $105,000

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $426M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.